At present, BNP and troponin are the main clinical biomarkers for the diagnosis of cardiovascular diseases, but they are mainly used for the diagnosis of heart failure and myocardial infarction, and have no significant significance for the diagnosis of AF. Here, NPPB is linked to atrial fibrillation.